Thu, Jan 21, 2021 5:10 PM
Kajaria Ceramics registers robust increase in Q3 PAT to Rs121.03 crore
A Flip by Flipitnews
Vertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion in revenue last year. While there is still more room for the business to get bigger, Vertex is already at a sizable market cap of $100 billion. Does this stock have enough runway to generate significant returns and help you become a millionaire.
Open Flip
Ashish Kacholia portfolio: Shares of Sanjivani Paranteral Ltd are one of the multibagger stocks that the Indian stock market has produced in recent years. This multibagger pharma stock has risen to the tune of 300 percent in the year but it seems that ace Indian stock investor Ashish Kacholia is still bullish on this small-cap stock.
Open Flip
Wall Street's fear gauge hit its highest in more than five months on Friday due to a sharp pullback in interest U.S. rate cut expectations and escalating geopolitical tensions. The CBOE Volatility index, an options-based measure of investor expectations for near-term stock market gyrations, hit 21.33 points, crossing the psychological mark of 20 points for the first time since Oct. 30, 2023.
Open Flip
